<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>DISEASE CHARACTERISTICS: Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> is characterized by <z:mp ids='MP_0000746'>weakness</z:mp> of ankle dorsiflexion and <z:hpo ids='HP_0002540'>inability to walk</z:hpo> on the heels after age 35 years </plain></SENT>
<SENT sid="1" pm="."><plain>Disease progression is slow and <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> remains confined to the anterior tibial muscles </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0010511'>long toe</z:hpo> extensors become clinically involved after ten to 20 years, leading to <z:hpo ids='HP_0003377'>foot drop</z:hpo> and <z:hpo ids='HP_0002312'>clumsiness</z:hpo> when walking </plain></SENT>
<SENT sid="3" pm="."><plain>In the mildest form, Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> can remain unnoticed even in the elderly </plain></SENT>
<SENT sid="4" pm="."><plain>DIAGNOSIS/TESTING: EMG shows profound <z:hpo ids='HP_0003198'>myopathic changes</z:hpo> in the anterior tibial muscle </plain></SENT>
<SENT sid="5" pm="."><plain>CT or MRI confirm fatty degeneration of the anterior tibial muscles and also show large patchy lesions in other clinically unaffected muscles </plain></SENT>
<SENT sid="6" pm="."><plain>Molecular genetic testing is clinically available for TTN, encoding the protein titin (TTN), which is the only gene known to be associated with Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> affected Finnish families have a <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> mutation termed FINmaj, a unique 11-bp deletion/insertion mutation that changes four <z:chebi fb="0" ids="33708">amino-acid residues</z:chebi> in exon Mex6 </plain></SENT>
<SENT sid="8" pm="."><plain>Six other mutations have been identified in exons Mex5 and Mex6 in families from different European populations </plain></SENT>
<SENT sid="9" pm="."><plain>MANAGEMENT: Treatment of manifestations: orthoses for <z:hpo ids='HP_0003377'>foot drop</z:hpo> early in the disease course; tibial posterior tendon transposition to replace lost function of the anterior tibial muscle and <z:hpo ids='HP_0010511'>long toe</z:hpo> extensor muscles when <z:hpo ids='HP_0003377'>foot drop</z:hpo> is severe </plain></SENT>
<SENT sid="10" pm="."><plain>Surveillance: neurologic examination every four months to evaluate gait and strength </plain></SENT>
<SENT sid="11" pm="."><plain>Agents/circumstances to avoid: heavy muscle force training of weak muscles </plain></SENT>
<SENT sid="12" pm="."><plain>GENETIC COUNSELING: Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> is inherited in an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> manner </plain></SENT>
<SENT sid="13" pm="."><plain>Most individuals diagnosed with Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> have an affected parent </plain></SENT>
<SENT sid="14" pm="."><plain>Each child of an individual with Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> has a 50% chance of inheriting the mutation </plain></SENT>
<SENT sid="15" pm="."><plain>Prenatal testing for Udd distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> for pregnancies at increased risk may be available through laboratories offering custom prenatal diagnosis if the causative mutation in a family is known </plain></SENT>
</text></document>